Interview with Gabor Somlyai, Managing Director, HYD LLC.
You founded HYD almost 20 years ago, in 1992. Can you first explain to our readers why you made the switch from doing research at the Hungarian Institute of Oncology…
Patent Ltd. was founded in 1989.
Our company mainly fabricates custom made stainless steel vessels for pharmaceutical, food and chemical industry. Beside that we have a serial production of special stainless steel structures for the energetics. To fulfill the needs of the the market, we are continuously improving our fabrication infrastructure.
Of course we are having the essential licenses for pressure vessel fabrications not only for Hungarian but also for the EU market. Our company has been qualified for the production of welded structures, pressure tanks and storage tanks of hazardous substances according to the requirements of DIN EN ISO 3834-2 / MSZ EN ISO 3834-2, AD 2000 Merkblatt HPO. We can fabricate according the requirements of 97/23/EK directive’s G; B1+F és B+F modul depending on the classification of the equipment. (PED)
We have a license to fabricate storage tanks for hazardous liquids and melts according to 11/1994 (III. 25.) IKM departmental order, and EN 15085 Railways Manufacturer’s Certificate.
And to be able to coordinate these special requirements we have established and introduced the MSZ EN ISO 9001-2008 quality assurance system.
Patent has relevant domestic and international experience, we are supplying a complex service from the design till the FAT (or till IQ, OQ). Depending the needs of our client the documentation we can supply in English, German or in Russian language.
Contact
2700 Cegléd, Bürgeházdűlő
Mail address: 2700 Cegléd, Pf.261
+36 30/439-0002
You founded HYD almost 20 years ago, in 1992. Can you first explain to our readers why you made the switch from doing research at the Hungarian Institute of Oncology…
Hungary has been recognized as one of the largest pharmaceutical and healthcare markets in Central and Eastern Europe, and can obviously not be ignored by Roche. First of all, can…
You took over as GM back in 2008. No doubt that this was a challenging time to run a business, in particular in view of the external economic environment. Can…
The Hungarian pharmaceutical environment has been undergoing a turbulent time recently, with many new measures being implement by the Government. What are your observations, and how do you expect companies…
Assign Group started in 2002 as a small local CRO company founded in Austria; monitoring and doing minor project management only. Why was Austria chosen as the headquarters? First, it…
With approximately $90 billion flowing into the country (according to the Hungarian Investment and Trade Agency) since it abolished its centrally planned economy and transformed into an open, pro-business economy…
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
IMS is a strong brand name when it comes to pharma and healthcare information worldwide. Can you please elaborate on the particularities that set the Hungarian pharmaceutical market apart from…
The Hungarian pharmaceutical environment has been undergoing many changes recently, such as a sales tax increase to 20%. Do you feel this is a climate of threat to MNCs in…
Hungary is one of the largest pharmaceutical markets in the region, and has been used by Janssen-Cilag as a hub. Can you elaborate on how important Hungary is for Janssen-Cilag…
Talking to Cegedim means talking to one of the experts in local market knowledge. Can you tell our readers from your point of view what really distinguishes Hungary from other…
Looking at Boehringer Ingelheim (BI) in Hungary, at first glance we see a company with a presence of already 20 years, which basically means an entry into this market right…
See our Cookie Privacy Policy Here
